Wang M - Search Results

1

Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes.

Zhou W, He Z, Xue J, Wang M, Zha X, Ling L, Chen L, Wang S, Liu X. Zhou W, et al. Among authors: wang m, wang s. PLoS One. 2012;7(4):e35881. doi: 10.1371/journal.pone.0035881. Epub 2012 Apr 26. PLoS One. 2012. PMID: 22563412 Free PMC article.

2

A novel finding of sentinel lymphatic channels in early stage breast cancer patients: which may influence detection rate and false-negative rate of sentinel lymph node biopsy.

Wang M, Zhou W, Zhao Y, Xia T, Zha X, Ding Q, Liu X, Zhao Y, Ling L, Chen L, Wang S. Wang M, et al. Among authors: wang s. PLoS One. 2012;7(12):e51226. doi: 10.1371/journal.pone.0051226. Epub 2012 Dec 4. PLoS One. 2012. PMID: 23226569 Free PMC article.

3

Variation of sentinel lymphatic channels (SLCs) and sentinel lymph nodes (SLNs) assessed by contrast-enhanced ultrasound (CEUS) in breast cancer patients.

Wang Y, Zhou W, Li C, Gong H, Li C, Yang N, Zha X, Chen L, Xia T, Liu X, Wang M, Ding Q. Wang Y, et al. Among authors: wang m. World J Surg Oncol. 2017 Jul 10;15(1):127. doi: 10.1186/s12957-017-1195-3. World J Surg Oncol. 2017. PMID: 28693494 Free PMC article.

4

Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients.

Zhao YC, Ni XJ, Wang MH, Zha XM, Zhao Y, Wang S. Zhao YC, et al. Med Oncol. 2012 Dec;29(4):2594-600. doi: 10.1007/s12032-012-0205-0. Epub 2012 May 6. Med Oncol. 2012. PMID: 22562155

5

The optimum marker for the detection of lymphatic vessels.

Kong LL, Yang NZ, Shi LH, Zhao GH, Zhou W, Ding Q, Wang MH, Zhang YS. Kong LL, et al. Mol Clin Oncol. 2017 Oct;7(4):515-520. doi: 10.3892/mco.2017.1356. Epub 2017 Jul 31. Mol Clin Oncol. 2017. PMID: 28855985 Free PMC article.

6

Effect of Carbon Nanoparticle Tracer Combined with Laparoscopy in the Treatment of Colon Cancer.

Wang L, Xu H, Zhang X, Zhang Y, Shi L, Wang M. Wang L, et al. Among authors: wang m. J Nanosci Nanotechnol. 2020 Oct 1;20(10):6007-6012. doi: 10.1166/jnn.2020.18598. J Nanosci Nanotechnol. 2020. PMID: 32384945

7

miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.

Wang Y, Chen L, Wu Z, Wang M, Jin F, Wang N, Hu X, Liu Z, Zhang CY, Zen K, Chen J, Liang H, Zhang Y, Chen X. Wang Y, et al. Among authors: wang n, wang m. BMC Cancer. 2016 Nov 15;16(1):826. doi: 10.1186/s12885-016-2862-4. BMC Cancer. 2016. PMID: 27842510 Free PMC article.

8

Total versus subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials.

Kong L, Yang N, Shi L, Zhao G, Wang M, Zhang Y. Kong L, et al. Among authors: wang m. Onco Targets Ther. 2016 Nov 7;9:6795-6800. doi: 10.2147/OTT.S110828. eCollection 2016. Onco Targets Ther. 2016. PMID: 27853375 Free PMC article.

9

Identifying the role of Wilms tumor 1 associated protein in cancer prediction using integrative genomic analyses.

Wu LS, Qian JY, Wang M, Yang H. Wu LS, et al. Among authors: wang m. Mol Med Rep. 2016 Sep;14(3):2823-31. doi: 10.3892/mmr.2016.5528. Epub 2016 Jul 18. Mol Med Rep. 2016. PMID: 27430156

10

Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction.

Wang M, Wei X, Shi L, Chen B, Zhao G, Yang H. Wang M, et al. Int J Mol Med. 2014 Apr;33(4):1019-26. doi: 10.3892/ijmm.2014.1649. Epub 2014 Feb 10. Int J Mol Med. 2014. PMID: 24535227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68,010 results

Search Page

Filters